January 2023 - SCPC | Senior Care Pharmacy Coalition

Jan 20, 2023

Senior Care Pharmacy Coalition Provides Comments on Improving Care for Dually Eligible Enrollees

The Senior Care Pharmacy Coalition (SCPC), the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies, has responded to a Request for Information issued by a bipartisan group of Senators led by Senator Bill Cassidy (R-LA) regarding policy recommendations to improve care for enrollees dually eligible for Medicare and Medicaid programs (dual eligibles) and substantially reduce the amount of money both programs otherwise would expect to spend over time.

Jan 7, 2022

Prescription Drug Policy, 2021 And 2022: The Year In Review, And The Year Ahead

By Rachel Sachs Health Affairs This past year was filled with news in the prescription drug policy area, from the Food and Drug Administration’s (FDA) most controversial drug approval in many years to ongoing discussions in Congress over drug pricing reform. Through it all, the importance of responding to the COVID-19 pandemic has remained at […]

Jan 6, 2021

SCPC Seeks Specific Guidance on COVID-19 Vaccine Access for Patient-Facing Long-Term Care Pharmacy Staff

By Overlooking Necessary Health Care Personnel Who Provide Essential Services in Long Term Care Facilities, Public-Health Decision Makers Put Patients at Greater Risk Washington, DC – The Senior Care Pharmacy Coalition (SCPC) issued letters to federal and state officials yesterday seeking specific guidance on COVID-19 vaccine access for patient-facing long-term care (LTC) pharmacy health care […]

Jan 29, 2020

To Boost Transparency, SCPC Seeks to Amend Senate, House Bills to Require PBM Disclosure Data Related to Seniors Residing in LTC Facilities

Washington, DC – To better ensure the Centers for Medicare and Medicaid Services (CMS) and consumers have access to drug pricing information relevant to seniors residing in long term care (LTC) facilities, the Senior Care Pharmacy Coalition (SCPC) today suggested that the Senate Finance Committee-introduced Prescription Drug Pricing Reduction Act (PDPRA) and the Lower Cost, […]

Jan 27, 2020

Bill to eliminate third-party pharmacy benefit managers could save state millions

Fox 25 Oklahoma – January 24, 2020 By Destiny Washington OKLAHOMA CITY (KOKH) — Oklahoma could soon join the growing number of states backing away from using Pharmacy Benefit Managers (PBM’s) to administer prescription-drug programs. A PBM is a third-party administrator of prescription drug programs for state and federal government employee plans, self-insured employer plans, commercial […]

Jan 23, 2020

SCOTUS Can Rein in Middlemen Who Are Gaming Local Pharmacies, Patients

Morning Consult– January 23, 2020 By B. Douglas Hoey Very few people know what pharmacy benefit managers do. The three biggest rival the largest corporations in the world in terms of market capitalization, revenue and profits. The CVS Health pharmacy service segment, for example, reported $134 billion in revenue last year. The PBMs exert enormous influence on […]

Jan 16, 2020

New advocacy tool offers lawmaker education about long-term care pharmacy clinical value, benefits

McKnight’s Long-Term Care News– January 13, 2020 By Fred Burke As every practitioner and advocate within our broader long-term care space knows, it’s becoming increasingly difficult to break through the noise when it comes to engaging with and educating policymakers about the intrinsic value the long-term care community provides. Given the health challenges America faces, […]

Jan 9, 2020

More Than Half Of Voters Say Health Care, Drug Costs Are Top 2020 Concern

Inside Health Policy – January 08, 2020 By Emily Martin More than half of voters consider out-of-pocket costs for prescription drugs and other aspects of health care as top concerns ahead of the first primaries, according to a recent poll from Morning Consult and Bipartisan Policy Center. Nearly half also say use of illicit drugs and […]

Jan 29, 2019

National LTC Pharmacy Group: Senate, House Drug Pricing Hearings Kick-Off Vital 2019 Discussion on Transparency, Accountability, Reform

SCPC Urges Sweeping Congressional Focus on PDP/PBM Abuses, Culpability in Market Manipulation…